Heart MRI scans to study heart changes in adults with type 2 diabetes
Uses heart MRI scans to study heart changes in adults with type 2 diabetes.
Plain-language title generated from the registry record
Registry title: CMR in T2DM: The NSR Cohort
Key facts
- Where
- Slagelse, DenmarkSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT05915260, who can take part
Where in Denmark
- Slagelse Hospital, department of cardiology and endocrinology, medicine 2Slagelse, DenmarkNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Slagelse Hospital
- Trial code
- NCT05915260
- Record updated
- 22 June 2023
- Original description
This study aims to investigate the myocardial phenotype of patients with type 2 diabetes. From 2016-2019 the investigators recruited a cohort of 296 subjects with type 2 diabetes. All subjects underwent clinical examinations including a gadolinium contrast cardiac MRI.Read full original descriptionShow less
Cardiac Magnetic Resonance Imaging in Type 2 Diabetes Mellitus: The Næstved/Slagelse/Ringsted Cohort
This study aims to investigate the myocardial phenotype of patients with type 2 diabetes. From 2016-2019 the investigators recruited a cohort of 296 subjects with type 2 diabetes. All subjects underwent clinical examinations including a gadolinium contrast cardiac MRI.
The current study is a clinical follow-up study of the subjects, thus, the investigators will invite all participants to a reevaluation with cardiac MRI.
Additionally, the investigators will aim at recruiting additionally 400 patients with type 2 diabetes.
The aim it to characterize the phenotype of diabetic cardiomyopathy. Uniquely using cardiac MRI we can measure myocardial microvascular function, myocardial localised and diffuse fibrosis in addition to the quantification of myocardial structure and systolic and diastolic function.
Inclusion: Few and simple, allowing for a broad cohort; Male or female fully capable of providing informed consent; Informed consent; Age 18-80 (both included); T2DM diagnosed at least 3 months prior to inclusion in the study.